Leukemic transformation induces the constitutive expression of indoleamine 2,3-dyoxigenase which directly increases CD4+CD25+ T regulatory cells

被引：0
|
作者：
Curti, A
Pandolfi, S
Aluigi, M
Valzasina, B
Isidori, A
Ferri, E
Rutella, S
Durelli, I
Horenstein, AL
Fiore, F
Massaia, M
Piccioli, M
Palmerini, E
Pileri, S
Colombo, MP
Baccarani, M
Lemoli, RM
机构：
[1] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, Bologna, Italy
[2] S Orsola M Malpighi Hosp, Stem Cell Ctr, Bologna, Italy
[3] Ist Nazl Studio & Cura Tumori, Immunotherapy & Gene Therapy Unit, I-20133 Milan, Italy
[4] Catholic Univ, Sch Med, Dept Hematol, Rome, Italy
[5] Univ Turin, Dept Genet Biol & Biochem, Res Ctr Expt Med, CeRMS, Turin, Italy
[6] Univ Turin, Div Ematol, Turin, Italy
[7] CeRMS, Lab Ematol Oncol, Turin, Italy
[8] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, S Orsola M Malpighi Hosp, Hematol Unit, Bologna, Italy
[9] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, S Orsola M Malpighi Hosp, Haematopathol Unit, Bologna, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1210
引用
收藏
页码：353A / 353A
页数：1
相关论文
共 50 条
  • [41] Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25
    Saito, Koji
    Wagatsuma, Toshihiro
    Toyama, Hiroaki
    Ejima, Yutaka
    Hoshi, Kunihiko
    Shibusawa, Masakazu
    Kato, Masato
    Kurosawa, Shin
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 216 (01): : 61 - 68
  • [42] TNFR25 expression on CD4+CD25+ T cells:: Down modulation of regulatory activity.
    Deyev, Vadim
    Roskos, Melinda
    Levy, Robert B.
    Podack, Eckhard R.
    BLOOD, 2006, 108 (11) : 903A - 903A
  • [43] CD4+CD25+ regulatory T cells in patients with acute lymphocytic leukemia
    Cao, Xiangshan
    Xie, Xiaobao
    Li, Aaihua
    Qiu, Guoqiang
    BLOOD, 2007, 110 (11) : 38B - 38B
  • [44] Suppression of PPD induced responses by CD4+CD25+ regulatory T cells
    Vukmanovic-Stejic, M
    Taams, LS
    Reed, JR
    Smith, J
    Fletcher, JM
    Dunne, PJ
    Salmon, M
    Rustin, MH
    Akbar, AN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 310 - 310
  • [45] CD4+CD25+ regulatory T cells:: a therapeutic target for liver diseases
    Zheng, Ming-Hua
    Gu, Dian-Na
    Braddock, Martin
    Leishman, Andrew J.
    Jin, Chang
    Wen, Jin-Sheng
    Gong, Yue-Wen
    Chen, Yong-Ping
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (03) : 313 - 326
  • [46] Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cells
    Sumpter, Tina L.
    Payne, Kyle K.
    Wilkes, David S.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (03) : 708 - 717
  • [47] Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells
    Fei, Fei
    Yu, Yingzhe
    Schmitt, Anita
    Rojewski, Markus Thomas
    Chen, Baoan
    Goetz, Marlies
    Doehner, Hartmut
    Bunjes, Donald
    Schmitt, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (02) : 195 - 205
  • [48] Another round for the CD4+CD25+ regulatory T cells in patients with tuberculosis
    Antas, Paulo R. Z.
    Sampaio, Elizabeth P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (02) : 214 - 215
  • [49] CD4+CD25+ regulatory T cells mediate acquired transplant tolerance
    Oluwole, SF
    Oluwole, OO
    DePaz, HA
    Adeyeri, AO
    Witkowski, P
    Hardy, MA
    TRANSPLANT IMMUNOLOGY, 2003, 11 (3-4) : 287 - 293
  • [50] Avian CD4+CD25+ regulatory T cells: Properties and therapeutic applications
    Selvaraj, Ramesh K.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2013, 41 (03): : 397 - 402
12345